Pharmacists in Ambridge, Pennsylvania


13 Pharmacists found in Ambridge
female pharmacist

Amanda Adora Cremeans, PHARMD


Pharmacist
300 8th St, Ambridge, PA 15003
724-266-9194    

female pharmacist

Barbara Ann Dennison, R.PH.


Pharmacist
643 Merchant St, Ambridge, PA 15003
724-266-4400     724-266-4411

male pharmacist

Bradley Campbell


Pharmacist
300 8th St, Ambridge, PA 15003
724-266-9194    



female pharmacist

Cayla Jones, PHARMD


Pharmacist
643 Merchant St, Ambridge, PA 15003
888-885-2828     855-483-9122

female pharmacist

Deidra Halapin, RPH, PHARMD


Pharmacist
300 8th St, Ambridge, PA 15003
724-266-9194    

female pharmacist

Heather Zuzo, RPH


Pharmacist
643 Merchant St, Ambridge, PA 15003
724-266-4400     855-483-9122

male pharmacist

Mr. James Augustine, RPH


Pharmacist
643 Merchant St, Ambridge, PA 15003
724-266-4400     855-483-9122

female pharmacist

Dr. Megan Petersen, PHARMD


Pharmacist
300 8th St, Ambridge, PA 15003
724-266-9194    

male pharmacist

Dr. Nicholas Joseph Bozza, PHARMD


Pharmacist
925 Merchant St, Ambridge, PA 15003
724-266-7664    

male pharmacist

Nicholas Francesco Cerminaro, PHARMD


Pharmacist
925 Merchant St, Ambridge, PA 15003
724-266-7664    

male pharmacist

Ryan Paul Durbin, PHARMD


Pharmacist
925 Merchant St, Ambridge, PA 15003
724-266-7664    

female pharmacist

Ms. Theresa Marie Gnjatovich, R.PH., CGP


Pharmacist - Geriatric
331 Merchant St, Ambridge, PA 15003
717-329-1302     412-734-6944

male pharmacist

Thomas Raymond Poole, RPH


Pharmacist
925 Merchant St, Ambridge, PA 15003
724-266-7664     724-266-3204


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.